CCM
NVO

Covington Capital Management’s Novo Nordisk NVO Stock Holding History

Covington Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$3.97M Sell
79,736
-3,384
-4% -$181K 0.17% 133
2022
Q2 		$4.63M Sell
83,120
-500
-0.6% -$27.7K 0.19% 130
2022
Q1 		$4.64M Sell
83,620
-104
-0.1% -$5.34K 0.17% 137
2021
Q4 		$4.69M Sell
83,724
-2,098
-2% -$114K 0.16% 137
2021
Q3 		$4.12M Buy
85,822
+6
+0% +$290 0.16% 143
2021
Q2 		$3.59M Sell
85,816
-830
-1% -$32.2K 0.14% 147
2021
Q1 		$2.92M Hold
86,646
– – 0.13% 150
2020
Q4 		$3.03M Sell
86,646
-2,700
-3% -$93.3K 0.14% 141
2020
Q3 		$3.1M Sell
89,346
-900
-1% -$30K 0.15% 138
2020
Q2 		$2.96M Sell
90,246
-92,170
-51% -$2.94M 0.16% 134
2020
Q1 		$5.49M Buy
182,416
+7,880
+5% +$235K 0.36% 79
2019
Q4 		$5.05M Sell
174,536
-2,290
-1% -$63.4K 0.27% 107
2019
Q3 		$4.57M Sell
176,826
-10,250
-5% -$259K 0.26% 106
2019
Q2 		$4.77M Sell
187,076
-47,230
-20% -$1.17M 0.28% 96
2019
Q1 		$6.13M Sell
234,306
-12,400
-5% -$305K 0.38% 82
2018
Q4 		$5.68M Sell
246,706
-2,604
-1% -$57.9K 0.4% 77
2018
Q3 		$5.88M Buy
249,310
+39,760
+19% +$970K 0.36% 81
2018
Q2 		$4.83M Buy
209,550
+25,610
+14% +$609K 0.31% 91
2018
Q1 		$4.53M Buy
183,940
+8,630
+5% +$227K 0.3% 93
2017
Q4 		$4.7M Buy
175,310
+4,704
+3% +$120K 0.29% 93
2017
Q3 		$4.11M Buy
+170,606
New +$3.86M 0.27% 98

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Covington Capital Management's NVO Position: Q3 2022 in Review

Covington Capital Management reduced its Novo Nordisk (NVO) stake by 4.1% in Q3 2022, selling an estimated $181K and leaving 79,736 shares worth $3.97M. The position accounts for 0.17% of the portfolio, ranked #133.

Covington Capital Management first reported a position in NVO in Q3 2017 and has held it in 21 quarters since. The position peaked at $6.13M in Q1 2019. 908 funds tracked by Wall St. Rank hold NVO as of Q3 2022.

  • Covington Capital Management held 79,736 shares of Novo Nordisk worth $3.97M as of Q3 2022.
  • Covington Capital Management sold 3,384 Novo Nordisk shares in Q3 2022, an estimated $181K.
  • Novo Nordisk made up 0.17% of Covington Capital Management's portfolio in Q3 2022, its #133 holding.
  • Covington Capital Management first reported a position in Novo Nordisk in Q3 2017 and has held it in 21 quarters since.
  • Covington Capital Management's Novo Nordisk position peaked at $6.13M in Q1 2019.
  • 908 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.

Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.